Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 11 - 14 tags : Biopharma save search
ABVC BioPharma Reports Third Quarter 2022 Financial and Operational Results
Published: 2022-11-14 (Crawled : 00:00) - globenewswire.com
ABVC | $0.9899 -5.72% -6.07% 160K
|
Wholesale Trade
|
| O: 6.6%
H: 0.0%
C: -10.39%
biopharma financial results
Cue Biopharma Announces $30 Million Private Investment in Public Equity (PIPE) Financing
Published: 2022-11-14 (Crawled : 14:00) - biospace.com/
CUE | $1.57 -0.63% -0.64% 170K
|
Health Technology
|
| O: -0.64%
H: 5.45%
C: 4.17%
biopharma cue
POINT Biopharma Reports Third Quarter 2022 Financial Results and Announces Strategic Collaboration and Exclusive License Agreements with Lantheus Holdings
Published: 2022-11-14 (Crawled : 12:20) - globenewswire.com
PNT | $13.68 2.63% 0.15% 0
|
|
| O: -11.71%
H: 2.53%
C: -29.12%
LNTH | $63.8 2.36% 2.3% 800K
|
Health Technology
|
| O: -0.41%
H: 3.77%
C: 1.8%
biopharma collaboration license financial results
Lantheus and POINT Biopharma Announce Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003
Published: 2022-11-14 (Crawled : 12:00) - globenewswire.com
PNT | $13.68 2.63% 0.15% 0
|
|
| O: -11.71%
H: 2.53%
C: -29.12%
LNTH | $63.8 2.36% 2.3% 800K
|
Health Technology
|
| O: -0.41%
H: 3.77%
C: 1.8%
pnt2002 biopharma collaboration commercialization license
Best Places to Work in Biopharma 2023 Report Reveals Most Sought-After Employers
Published: 2022-11-14 (Crawled : 09:00) - biospace.com/
STRO | $3.635 -3.58% -3.71% 520K
|
Health Technology
|
| O: 0.28%
H: 9.49%
C: 5.09%
biopharma work report
Akeso's Ivonescimab (PD-1/VEGF Bispecific Antibody, AK112) Granted Breakthrough Therapy Designation for I-O Resistance NSCLC Patients in China Akeso, Biopharma announced that the Center for Drug Evalua...
Published: 2022-11-14 (Crawled : 06:00) - biospace.com/
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.35%
H: 4.08%
C: 1.47%
ASND | $140.19 -0.5% -0.5% 270K
|
Health Technology
|
| O: -13.42%
H: 4.11%
C: -3.5%
ak112 biopharma designation drug granted china therapy
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
KUKE | $2.88 2.49% 7.64% 360K
|
SYY | $76.73 1.44% 5.49% 2.5M
|
Distribution Services
TWI | $11.53 0.96% 4.94% 330K
|
Producer Manufacturing
BTCM | $1.99 -6.13% 4.52% 75K
|
Arts, Entertainment, and Recrea...
MPLN | $0.6502 -11.74% 4.51% 2.2M
|
Finance
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
UHS | $157.47 2.49% 4.13% 900K
|
Health Services
PVL 4 | $1.47 -0.68% 4.08% 77K
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.